Pfizer出售Haleon股份,减少股份,为核心企业筹集资金。 Pfizer to sell shares of Haleon, reducing its stake and raising funds for core businesses.

Pfizer计划出售以Sensodyne牙膏公司为名的Haleon公司约7亿股,将其股份从15.7%左右减少到7.3%。 Pfizer plans to sell about 700 million shares of Haleon, the company known for Sensodyne toothpaste, reducing its stake from around 15.7% to about 7.3%. 预计这一举措将为辉瑞公司筹集大量资金,帮助其投资于核心企业和研究。 This move is expected to raise significant funds for Pfizer, helping it invest in core businesses and research. 这些股份将通过摩根斯坦利和JP摩根大通公司牵头的加速书业建设进程出售。 The shares will be sold through an accelerated book-building process led by Morgan Stanley and JPMorgan Chase & Co.